The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?
Authors:
Open Access
- 1 August 2025
- journal article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 16 (4) , 1768-1772
Abstract
The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?Keywords
This publication has 18 references indexed in Scilit:
- Questioning Why More Patients With Colorectal Liver Metastases Are Not Referred for MetastasectomyJAMA Surgery, 2020
- Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?Surgery, 2018
- Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver MetastasesJournal of the American College of Surgeons, 2018
- The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon CancerAnnals of Surgical Oncology, 2017
- Bevacizumab and wound-healing complications: a systematic review and meta-analysis of randomized controlled trialsOncotarget, 2016
- Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomesHPB, 2016
- Surgical Referral for Colorectal Liver Metastases: A Population-Based SurveyAnnals of Surgical Oncology, 2015
- Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III StudyOncology, 2010
- Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer PatientsAnnals of Surgical Oncology, 2009
- Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II StudyJournal of Clinical Oncology, 2005